You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK):中期銷售額不少於9億港元 同比下降不超16%
格隆匯 10-15 07:55

格隆匯 10 月 15日丨香港醫思醫療集團(02138.HK)發佈公告,截至2020年9月30日止六個月,集團預期錄得:銷售額不少於a.截至2020年6月30日止三個月期間4.6億港元;b.截至2020年9月30日止三個月期間4.4億港元;及c.期內銷售額不少於9億港元,期內銷售額較去年同期下降不多於16%;(ii)期內中國內地診所以及服務中心的銷售額較去年同期增長不少於30%;及(iii)期內集團所提供的醫療服務銷售額較去年同期增長不少於25%。

根據香港政府入境處統計,2020年10月1日至10月7日期間的中國大陸訪港客運量為約1,000人次,較去年同期下降約100%。由於所提供的醫療服務組合的增加,集團亦公佈於2020年10月1日至10月10日期間的未經審核的銷售額較去年同期錄得增長不少於15%。

期內,儘管新型冠狀病毒疾病爆發導致香港入境以及社交距離限制帶來了不利影響,(i)集團預期期內淨溢利較去年同期有所下調;(ii)期內於香港及中國內地診所及服務中心的客户到診人數分別增長超過5%及25%;(iii)集團總體財務狀況維持穩健。集團於期內通過調整策略主動與客户互動及進行促銷活動以刺激中國內地以及香港本地客户消費,及完成收購專科醫療產業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account